[HTML][HTML] Therapeutic Drug Monitoring in Oncohematological Patients: A Fast and Accurate HPLC-UV Method for the Quantification of Nilotinib in Human Plasma and …
V Escudero-Ortiz, FJ Rodríguez-Lucena… - Biomedicines, 2023 - mdpi.com
Nilotinib, a second-generation tyrosine kinase inhibitor, has demonstrated clinical activity in
chronic myeloid leukemia. As an exposure–response relationship has been observed for …
chronic myeloid leukemia. As an exposure–response relationship has been observed for …
[HTML][HTML] Chemical stability of ondansetron hydrochloride with other drugs in admixtures via parenteral; a review
…, I Jiménez-Pulido, FJ Rodríguez-Lucena… - Farmacia …, 2017 - Elsevier
Objective This review was prepared to offer the most complete information about the use of
ondansetron in parenteral admixtures with other drugs. Method The search was done from …
ondansetron in parenteral admixtures with other drugs. Method The search was done from …
Systematic screening of gender violence and domestic violence among HIV-positive patients: the VIHOLETA study
…, M Amat Díaz, S Padilla Urrea, FJ Rodríguez Lucena… - AIDS care, 2023 - Taylor & Francis
We conducted a multicentre observational study in people living with HIV (PLHIV) on
antiretroviral therapy in Alicante (Spain) from 2019 to 2020 aiming to analyse the prevalence …
antiretroviral therapy in Alicante (Spain) from 2019 to 2020 aiming to analyse the prevalence …
[PDF][PDF] A rapid validated UV-HPLC method for the simultaneous determination of the antiretroviral compounds darunavir and raltegravir in their dosage form.
…, L Soriano-Irigaray, FJ Rodríguez-Lucena… - Revista Española de …, 2017 - seq.es
Introduction. A rapid, simple and sensitive high-performance liquid chromatography (HPLC)
method with ultraviolet detection has been developed for quantification of darunavir and …
method with ultraviolet detection has been developed for quantification of darunavir and …
[PDF][PDF] Administración de medicamentos por vía subcutánea en cuidados paliativos
C Matoses Chirivella, FJ Rodríguez Lucena… - Farmacia …, 2015 - SciELO Espana
MATOSES CHIRIVELLA, Carmen et al. Administración de medicamentos por vía
subcutánea en cuidados paliativos. Farm Hosp.[online]. 2015, vol. 39, n. 2, pp. 71-79. ISSN …
subcutánea en cuidados paliativos. Farm Hosp.[online]. 2015, vol. 39, n. 2, pp. 71-79. ISSN …
[HTML][HTML] Pharmacokinetic monitoring of chronic treatment with digoxin from primary health care
EM García-Iranzo, FJ Rodríguez-Lucena… - Farmacia …, 2017 - Elsevier
Objetive To assess the pharmacokinetic monitoring of SDC performed from primary
healthcare (PH) in patients with chronic treatment. Methods Cross-sectional retrospective …
healthcare (PH) in patients with chronic treatment. Methods Cross-sectional retrospective …
Stability and compatibility of ondansetron with haloperidol in parenteral admixtures
…, AC Murcia-López, FJ Rodríguez-Lucena… - European Journal of …, 2018 - ejhp.bmj.com
Background The chemical stability of coadministered ondansetron (OND) and haloperidol
(HAL) in parenteral admixtures has not been described yet. Objective The aim of the present …
(HAL) in parenteral admixtures has not been described yet. Objective The aim of the present …
Subcutaneous drug administration in palliative care
RL FJ, ML AC - … : Organo Oficial de Expresion Cientifica de la …, 2015 - europepmc.org
Objective Develop a guide that compiles all the information available in the literature for
healthcare staff on the administration of drugs subcutaneously in palliative care patients of …
healthcare staff on the administration of drugs subcutaneously in palliative care patients of …
Six months multicentre pilot open label single‐arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled …
…, FJ Rodríguez‐Lucena… - Journal of Clinical …, 2022 - Wiley Online Library
Abstract What Is Known and Objective The study aimed to assess acceptability and patient
experience of Certolizumab (CZP) self‐injection with AVA® and clarify patient device …
experience of Certolizumab (CZP) self‐injection with AVA® and clarify patient device …
[HTML][HTML] Seguimiento farmacocinético del tratamiento crónico con digoxina desde Atención Primaria
EM García-Iranzo, FJ Rodríguez-Lucena… - Farmacia …, 2017 - SciELO Espana
Resumen GARCIA-IRANZO, Emma M et al. Pharmacokinetic monitoring of chronic treatment
with digoxin from Primary Health Care. Farm Hosp.[online]. 2017, vol. 41, n. 4, pp. 527-532 …
with digoxin from Primary Health Care. Farm Hosp.[online]. 2017, vol. 41, n. 4, pp. 527-532 …